innovation
Discover the opnMe program on December 8: 100 preclinical molecules donated by Boehringer Ingelheim
The Department of Applications of Research and Relations with Industrials (DARRI) is inviting you to join the team in the Jules Bordet room on December 8, from 11am to 12 noon, to discover the Boehringer Ingelheim (BI) group’s open innovation program, opnMe.
Florian Montel, Head of Open Science and opnMe at Boehringer Ingelheim, will be presenting the full opnMe offering, in particular grants available for postdocs and the option to apply for regular calls for proposals, as well as free access to a preclinical molecule catalog.
A partner like no other
Boehringer Ingelheim (BI) is no ordinary pharma. Founded in 1885 and to this day managed by the founding family, it is one of the world's top 20 laboratories – and the biggest in the sector to be fully independent and unlisted.
This independent status has direct consequences for us: BI can commit to long-term research collaborations, make quick decisions, and take risks with exploratory projects that are often judged severely by listed companies. The partnership is a cornerstone of our innovation strategy: research collaborations, licenses, co-developments, seed funds – and an online open submission portal.
With opnMe, the group is taking this logic even further: open innovation.
OpnMe: a three-pronged program
- Collaborative calls for proposals, with industrial postdoc funding.
A tangible way to fund a topic while building a direct bridge between Institut Pasteur and Boehringer Ingelheim laboratories.
- Thematic calls for proposals launched several times a year.
The format is intentionally lightweight: short, non-confidential proposals, and – something rare – all applicants receive a reply, even those who are not selected.
- A catalog of more than 100 preclinical molecules provided free of charge.
Scientists can access molecules for their research for free. These can be used for exploratory studies, repurposing tests, mechanisms of action, etc. with collaboration potential afterwards if the results are conclusive.
The DARRI hopes that lots of you can come along on December 8!